Concomitant medical products: product id 8709, lot# j0056604r, implanted:(b)(6) 2000, explanted:(b)(6) 2022, and product type: catheter.Product id 8578, serial# (b)(4), implanted:(b)(6) 2009, explanted: (b)(6) 2022, and product type: catheter.Other relevant device(s) are: product id: 8709, serial/lot #: (b)(4), and udi#: (b)(4).Product id: 8578, serial/lot #: (b)(4), ubd: (b)(6) 2010, and udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
Information was received from a healthcare provider (hcp) via a company representative regarding a patient receiving infumorph (25 mg/ml at 6.2 mg/day) via an implanted pump.It was reported that the patient was having a pump replacement procedure for end of battery life.During the procedure, the hcp noted no csf (cerebrospinal fluid) flow through the catheter access port and no flow of csf after cutting the catheter.The pump volumes had been correct, and no patient symptoms had been reported.There was a strange black colored substance around the collar of the pump connector after removing the existing catheter from the pump connector.There were no known environmental, external, or patient factors that may have led or contributed to the issue aside from the catheter being (b)(6).A new catheter was implanted, and the issue was noted to be resolved.Following the procedure, the infumorph dose was reduced to 3.1 mg/day.
|